4//SEC Filing
Campbell Bradley L 4
Accession 0000950170-25-025118
CIK 0001178879other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:27 PM ET
Size
8.2 KB
Accession
0000950170-25-025118
Insider Transaction Report
Form 4
Campbell Bradley L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-02-19$9.03/sh+400$3,612→ 1,151,057 total - Sale
Common Stock
2025-02-19$10.00/sh−400$4,000→ 1,150,657 total - Exercise/Conversion
Stock Options (right to buy)
2025-02-19−400→ 99,600 totalExercise: $9.03Exp: 2026-01-04→ Common Stock (400 underlying)
Footnotes (1)
- [F1]All of the options were fully vested and exercisable as of the transaction date.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001400971
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 7:27 PM ET
- Size
- 8.2 KB